comparemela.com
Home
Live Updates
Aridis Pharmaceuticals Announces First Quarter 2022 Financial Results and Business Update : comparemela.com
Aridis Pharmaceuticals Announces First Quarter 2022 Financial Results and Business Update
/PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...
Related Keywords
Russia
,
India
,
Ukraine
,
Los Gatos
,
Vu Truong
,
Aridis Pharmaceuticals
,
Data Safety Monitoring Committee
,
Aridis Pharmaceuticals Inc
,
Prnewswire Aridis Pharmaceuticals Inc
,
Cystic Fibrosis Foundation
,
Innovative Medicines Initiative
,
Nasdaq
,
Development Expenses
,
Serum Institute Of India
,
Clinical Program
,
Redchip Companies
,
Company Phase
,
Drug Administration
,
European Commission
,
Cf Foundation
,
Exchange Commission
,
Kermode Biotechnologies Inc
,
European Medicines Agency
,
Gates Foundation
,
Ventilator Associated Pneumonia
,
Chief Executive Officer
,
Orphan Drug Designation
,
Fast Track
,
Qualified Infectious Disease Product
,
Eastern Europe
,
Scientific Advisory
,
Quarter Financial Results
,
Kermode Biotechnologies
,
Administrative Expenses
,
Infectious Diseases
,
Serum Institute
,
Consolidated Statements
,
Nc
,
comparemela.com © 2020. All Rights Reserved.